Results 221 to 230 of about 1,334,045 (336)

Effect of timed exercise interventions on patient-reported outcome measures: A systematic review. [PDF]

PLoS One
Karavetian M, El Khoury CF, Rutters F, Slebe R, Lorenzetti D, Blondin D, Carpentier A, Després JP, Hoeks J, Kalsbeek A, de Mutsert R, Pigeyre M, Raina P, Schrauwen P, Serlie M, Thieba C, van der Velde J, Campbell DJT.   +17 more
europepmc   +1 more source

Validation of the Crohn’s Life Impact Questionnaire (CLIQ), the First Patient-Reported Outcome Measure Specific to Adults with Crohn’s Disease [PDF]

, 2013
Jeanette Wilburn, Stephen P. McKenna, James Twiss, Karen Kemp, S. Campbell   +4 more
openalex   +1 more source

The critical role of DNA damage‐inducible transcript 4 (DDIT4) in stemness character of leukemia cells and leukemia initiation

Molecular Oncology, EarlyView.
Stemness properties, including quiescence, self‐renewal, and chemoresistance, are closely associated with leukemia relapse. Here, we demonstrate that DNA damage‐inducible transcript 4 (DDIT4) is induced in the hypoxic bone marrow niche and is essential for maintaining the stemness of AML1‐ETO9a leukemia cells.
Yishuang Li, Zhijie Cao, Haiyan Xing, Zhenya Xue, Wenbing Liu, Jiayuan Chen, Yihan Mei, Runxia Gu, Hui Wei, Shaowei Qiu, Min Wang, Qing Rao, Jianxiang Wang   +12 more
wiley   +1 more source

A new generation of patient-reported outcome measures with large language models. [PDF]

J Patient Rep Outcomes
Terheyden JH, Pielka M, Schneider T, Holz FG, Sifa R.   +4 more
europepmc   +1 more source

Repeated Measure Analysis of Dermatitis Symptoms Evolution and Patient-Reported Outcome in N06C4: A Phase 3 Randomized Trial of Mometasone Furoate in Breast Cancer Patients Receiving Radiation Therapy [PDF]

, 2013
Terence T. Sio, Diane Schwartz, Philip J. Atherton, Michelle A. Neben Wittich, Patricia Griffin, James A. Martenson, Jeff A. Sloan, Roscoe F. Morton, Charles L. Loprinzi, Robert C. Miller   +9 more
openalex   +1 more source

Unveiling unique protein and phosphorylation signatures in lung adenocarcinomas with and without ALK, EGFR, and KRAS genetic alterations

Molecular Oncology, EarlyView.
Proteomic and phosphoproteomic analyses were performed on lung adenocarcinoma (LUAD) tumors with EGFR, KRAS, or EML4–ALK alterations and wild‐type cases. Distinct protein expression and phosphorylation patterns were identified, especially in EGFR‐mutated tumors. Key altered pathways included vesicle transport and RNA splicing.
Fanni Bugyi, Mirjam Balbisi, Simon Sugár, Lóránd Váncza, Eszter Regős, Ilona Kovalszky, Ibolya Laczó, Tünde Harkó, Gábor Kecskeméti, Zoltán Szabó, Judit Moldvay, László Drahos, Lilla Turiák   +12 more
wiley   +1 more source

A COSMIN systematic review of generic patient-reported outcome measures in Switzerland. [PDF]

Qual Life Res
Elsener T, Kerry M, Biller-Andorno N.
europepmc   +1 more source

Feasibility of 4 patient-reported outcome measures in a registry setting

, 2012
Aksel Paulsen, Alma B Pedersen, Søren Overgaard, Ewa M. Roos   +3 more
openalex   +2 more sources

Targeting of PTP4A3 overexpression sensitises HGSOC cells towards chemotherapeutic drugs

Molecular Oncology, EarlyView.
In HGSOC with normal KRAS expression, high PTP4A3 expression regulates autophagy activation. Conversely, in HGSOC with high KRAS expression, KRAS dictates autophagy control, and PTP4A3 is not required. When high PTP4A3 expression is inhibited, HGSOC cells are preferentially sensitised towards DNA‐damaging agents.
Ana López‐Garza, David James, Emma Creagh, James T. Murray   +3 more
wiley   +1 more source

Asthma self-knowledge patient-reported outcome measures for the paediatric population with asthma: a systematic review protocol. [PDF]

BMJ Open
Gonçalves AS, Simões PA, Gama JMR, Jácome C, Maricoto T.   +4 more
europepmc   +1 more source